Strata Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Buy
459
+126
+38% +$129K 0.13% 53
2026
Q1
$306K Sell
333
-7
-2% -$7.1K 0.08% 72
2025
Q4
$365K Buy
+340
New +$325K 0.1% 60
2025
Q3
Sell
-296
Closed -$231K 103
2025
Q2
$231K Sell
296
-115
-28% -$89.4K 0.06% 74
2025
Q1
$340K Sell
411
-232
-36% -$193K 0.11% 58
2024
Q4
$496K Sell
643
-15
-2% -$12.4K 0.16% 50
2024
Q3
$583K Buy
658
+35
+6% +$31.5K 0.19% 46
2024
Q2
$564K Sell
623
-711
-53% -$569K 0.19% 41
2024
Q1
$1.04M Buy
+1,334
New +$949K 0.37% 30

Other funds holding LLY

Strata Wealth Advisors's LLY Position: Q2 2026 in Review

Strata Wealth Advisors increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $129K and bringing the position to 459 shares worth $551K. The position accounts for 0.13% of the portfolio, ranked #53.

Strata Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.04M in Q1 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Strata Wealth Advisors held 459 shares of Eli Lilly worth $551K as of Q2 2026.
  • Strata Wealth Advisors bought 126 Eli Lilly shares in Q2 2026, an estimated $129K.
  • Eli Lilly made up 0.13% of Strata Wealth Advisors's portfolio in Q2 2026, its #53 holding.
  • Strata Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Strata Wealth Advisors's Eli Lilly position peaked at $1.04M in Q1 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strata Wealth Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.